Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients (Q28345475)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q23771643)
(Q118146296)
(P304) 42-7
(P407) (Q1860)
(P433) 1
(P478) 84
(P577) Friday, January 5, 2001
(P921) (Q181600)
(Q423762)
(P1433) (Q326309)
(P1476) "Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients" (language: en)
(P2093) M M Malingré
H Rosing
F J Koopman
R C Jewell
E M Paul
J H Schellens
(P2860) (Q36431370)
(Q36031211)
(Q36724323)
(Q47722866)
(Q41688645)
(Q41686982)
(Q41522468)
(Q51875835)
(Q41728013)
(Q44119231)
(Q43201882)
(Q51601468)
(Q72234861)
(Q72656539)
(Q72685142)
(Q72354126)
(Q71046859)
(Q71350403)
(Q71489103)
(Q71963294)
(Q71975363)
(Q95807142)
(Q77151159)
(Q77492890)
(Q77556097)
(Q73253464)
(Q73900866)
other details